Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Deborah Jane Holmes-Walker

Staff Specialist/Associate Professor

South Western Sydney Local Health District

Australia

Research Interests

Explore related searches

Professors in Australia

About

Deborah Jane Holmes-Walker is an Associate Professor at the Western Sydney Local Health District in Australia. Her research areas include the management of type 1 diabetes, with recent articles focusing on transitioning programs, machine learning applications in diabetes prediction, and the efficacy of treatments such as liraglutide and semaglutide. She is actively involved in studies aimed at improving clinical outcomes and cost-effectiveness in diabetes care.

Articles (16)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (15)

Elizabeth Davis

University of Western Australia

AUSTRALIA

Deborah Jane Holmes-Walker

Research Interests

Explore related searches

About

Articles (16)

Triple combination <scp>cystic fibrosis transmembrane receptor</scp> modulator effects on glycaemia and insulin kinetics in cystic fibrosis with and without diabetes

Improving glycaemic outcomes with subsidised access to diabetes technology in a young adult population with type 1 diabetes

A Narrative Review of the Metabolic Benefits of GLP-1 and GIP Receptor Agonists in Obesity

Twenty-One Years and Still Going Strong

Machine learning techniques to predict diabetic ketoacidosis and HbA1c above 7% among individuals with type 1 diabetes - A large multi-centre study in Australia and New Zealand

Effect of metformin on insulin resistance in adults with type 1 diabetes: a 26-week randomized double-blind clinical trial

Liraglutide for the Treatment of Severe Hypoglycemia Following Total Pancreatectomy and Islet Autotransplantation

Reducing cardiometabolic risk with semaglutide in type 1 diabetes (RESET1): Study protocol of a phase 2 double‐blinded randomised placebo‐controlled trial

Nationally Subsidized Continuous Glucose Monitoring: A Cost-effectiveness Analysis

Clinical and Radiologic Response of Central Giant Cell Granuloma to Denosumab: A 6-Year Prospective Observational Study

Universal Subsidized Continuous Glucose Monitoring Funding for Young People With Type 1 Diabetes: Uptake and Outcomes Over 2 Years, a Population-Based Study

Benchmarking care outcomes for young adults with type 1 diabetes in Australia after transition to adult care

Insulin resistance in type 1 diabetes managed with metformin (INTIMET): Study protocol of a double‐blind placebo‐controlled, randomised trial

Technologies in the management of type 1 diabetes

Letter to the Editor from Snaith et al: “Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry”

Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?

Collaborators (15)

Elizabeth Davis

Ella Zomer

Jerry R. Greenfield

Sarah J. Glastras

Craig F Munns

Dorit Samocha-Bonet

Greg Kowalski

Veslemøy Guise

Bruce King

Timothy Jones

Peter G Middleton

Ann Carrigan

Michelle Jack

Putu Novi Arfirsta Dharmayani

Samantha L. Hocking

Make your next move.